RxDoctor Payments Data

Javid Ghandehari

Pain Medicine · Santa Monica, CANPI 1306002761

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $187,266 of the $188,273 with a category attached, or 99.5%. Pfizer accounts for 99.5% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2024 at $143,234 and has fallen 69.3% since, to $44,032 in 2025. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$188,273in general payments, 2019–2025

Across 8 payments — averaging $23,534 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$187K
  • Vertex$1K
$2,514,697in research payments, 2019–2025

Across 8 payments — averaging $314,337 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amphastar Pharmaceuticals, Inc.$1.3M
  • E.r. Squibb & Sons, L.L.C.$1.1M
  • Beigene Switzerland GmbH$72K

What the payments were for

  • Consulting fees$187,26699%
  • Travel & lodging$9821%
  • Food & beverage$250%

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer2$187,266
Vertex6$1,007

How this compares

$188,273 in reported general payments places this provider in the 95th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California

Other pain medicine in Santa Monica

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →